Kaleorid

Potassium Chloride, the active ingredient in Kaleorid, is an electrolyte presented as an oral formulation for oral use. It is employed to restore normal serum potassium levels and to correct hypokalemia in patients requiring potassium supplementation. The compound provides potassium ions that are essential for cellular function, nerve impulse transmission, and muscle contraction, particularly in cardiac tissue.

GNH USA supplies Kaleorid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Kaleorid (potassium chloride) is used to manage electrolyte disorders, specifically hypokalemia.

- Hypokalemia: Restores serum potassium to normal levels in patients with low potassium. - Diuretic‑induced potassium loss: Replaces potassium lost during diuretic therapy. - Gastrointestinal potassium depletion: Corrects potassium deficits caused by vomiting or laxative use.

Kaleorid may cause adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: Mild stomach upset after ingestion. - Abdominal discomfort: Cramping or pain in the abdomen. - Diarrhea: Loose stools occurring shortly after dosing. - Vomiting: Involuntary expulsion of stomach contents. - Taste disturbance: Metallic or salty taste perception. - Flatulence: Excess gas formation.

Serious or Rare Side Effects: - Hyperkalemia: Excessively high serum potassium leading to cardiac arrhythmia. - Cardiac arrhythmia: Irregular heart rhythm that may be life‑threatening. - Severe allergic reaction: Rash, itching, swelling, or anaphylaxis. - Hyperchloremia: Elevated chloride levels causing metabolic acidosis. - Muscle weakness: Unusual loss of strength or fatigue. - Metabolic acidosis: Disturbance in blood pH due to electrolyte imbalance.

Before prescribing Kaleorid, clinicians should evaluate patient-specific factors and monitor relevant parameters. - Serum potassium monitoring: Check levels before initiation and regularly during therapy. - Renal function assessment: Adjust dose in patients with impaired kidney function. - Avoid in hyperkalemia: Do not use when serum potassium is already elevated. - Caution with ACE inhibitors or potassium‑sparing diuretics: Increased risk of hyperkalemia. - Pregnancy and lactation: Use only if benefits outweigh potential risks. - Store at ambient temperature: Keep below 25°C in the original packaging, protect from moisture.

Kaleorid can interact with several medications that affect potassium balance.

Major Interactions (Avoid): - ACE inhibitors: May cause additive hyperkalemia. - Potassium‑sparing diuretics (e.g., spironolactone): Increase risk of excessive potassium. - NSAIDs: Can reduce renal potassium excretion, raising serum levels.

Moderate Interactions (Monitor Closely): - Digoxin: Elevated potassium can enhance digoxin toxicity. - Lithium: Altered renal handling may affect lithium levels. - Certain antibiotics (e.g., penicillins): May increase potassium retention.